Navire Pharma

0 followers


Navire Pharma is developing SHP2 inhibitors as effective additions to the therapeutic arsenal for difficult-to-treat cancers.

Org chart

Co-Founders

Collapse
Uma Sinha
Chief Scientific Officer, BridgeBio
Eli Wallace
Chief Scientific Officer, Residence for Oncology
Pedro J. Beltran
SVP & Head of Biology for Oncology
Carl Dambkowski
Head of Clinical Strategy